"During my decade at Illumina Ventures, I evaluated countless genomics innovations, yet Arima’s approach stands out for its ability to illuminate aspects of the genome most tests never see," said ...
Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...
Arima Genomics, Inc. (Arima), a company leveraging 3D genomics to reveal actionable insights that will empower researchers and clinicians to improve human health, announced the publication of a study ...
SAN DIEGO--(BUSINESS WIRE)--Arima Genomics, Inc., the leader in 3D genomics, today announced the close of its $7 million Series B Preferred Stock financing round. New investors Genetron Health (NASDAQ ...
SAN DIEGO--(BUSINESS WIRE)--Arima Genomics, Inc., a company focused on research tools to accelerate the understanding of genome sequence and structure toward their role in human health and disease, ...
Arima Genomics, Inc., a company leveraging 3D genomics to reveal actionable insights to improve human health and drive discovery in the life sciences, today announced the formation of a clinical ...
Data from five presentations spanning lung, gastrointestinal, and gynecologic cancers highlight how structural variant analysis can expand what cancer genomics reveals Arima Genomics, Inc., a company ...
CARLSBAD, Calif., April 10, 2025--(BUSINESS WIRE)--Arima Genomics, Inc. (Arima), a company leveraging 3D genomics to reveal actionable insights that will empower researchers and clinicians to improve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results